flunixin meglumine has been researched along with Inflammation in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Borchardt, S; Gelfert, CC; Pieper, L; Schmitt, R; Staufenbiel, R; Swinkels, JM | 2 |
| Bishop, RC; Kemper, AM; McCoy, AM; Stewart, RM; Wilkins, PA | 1 |
| Bruckmaier, RM; Sintes, GF; Wellnitz, O | 1 |
| Arthur, RM; Goldin, S; Gretler, SR; Kass, PH; Knych, HK; McKemie, DS | 1 |
| Catala, M; Fournier, R; Roy, O; Thiry, J | 1 |
| Fosse, TK; Levionnois, OL; Ranheim, B | 1 |
| Johns, IC; Knowles, EJ; Linnenkohl, W; Mair, TS; Naylor, RJ; Taylor, AH; Wilford, S | 1 |
| Baynes, RE; Dutko, T; Gehring, R; Herges, G; Li, M; Riviere, JE; Schroeder, JW; Shelver, WL; Smith, DJ; Tell, L | 1 |
| Chiesa, OA; Deaver, C; Esparza, J; Jones, YL; Kenyon, E; Lancaster, V; Myers, MJ; Peters, SM; Screven, R; Stubbs, JT; Wiesenfeld, PL; Yancy, H; Yang, M | 1 |
| Jeremejeva, J; Kask, K; Orro, T; Waldmann, A | 1 |
| Cook, VL; Gandy, JC; Hauptman, JG; Holcombe, SJ; Jacobs, CC; Sordillo, LM | 1 |
| Bryant, CE; Farnfield, BA; Janicke, HJ | 1 |
| Higgins, AJ; Lees, P | 1 |
| Snow, D | 1 |
| Dalle, S; Daval, S; Espinasse, J; Garcia, J; Salat, O; Schelcher, F; Thouvenot, JP; Valarcher, JF | 1 |
| Magnusson, U; Odensvik, K | 1 |
| Cheng, Z; Lees, P; McKellar, Q; Nolan, A | 1 |
| Cheng, Z; McKellar, QA; Nolan, AM | 1 |
| Cheng, Z; McKeller, Q; Nolan, A | 1 |
| Krohne, SD; Vestre, WA | 1 |
6 trial(s) available for flunixin meglumine and Inflammation
| Article | Year |
|---|---|
Effects of a single transdermal administration of flunixin meglumine in early postpartum Holstein Friesian dairy cows: Part 1. Inflammatory and metabolic markers, uterine health, and indicators of pain.
Topics: Administration, Cutaneous; Animals; Cattle; Cattle Diseases; Female; Haptoglobins; Inflammation; Lactation; Milk; Pain; Parity; Postpartum Period; Pregnancy; Vaginal Discharge | 2023 |
Effects of a single transdermal administration of flunixin meglumine in early postpartum Holstein Friesian dairy cows: Part 2. Milk yield, culling risk, and reproductive performance.
Topics: Administration, Cutaneous; Animals; Cattle; Cattle Diseases; Female; Inflammation; Lactation; Parity; Postpartum Period; Pregnancy; Prospective Studies; Urea | 2023 |
PK/PD modeling of flunixin meglumine in a kaolin-induced inflammation model in piglets.
Topics: Analgesics; Animals; Animals, Newborn; Anti-Inflammatory Agents; Clonixin; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Injections, Intravenous; Kaolin; Pain Measurement; Swine | 2018 |
Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Endotoxins; Female; Horse Diseases; Horses; Inflammation; Intestinal Obstruction; Intestine, Small; Male; Meloxicam; Postoperative Complications; Thiazines; Thiazoles | 2014 |
Treatment of dairy cows with PGF2α or NSAID, in combination with antibiotics, in cases of postpartum uterine inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Cephalosporins; Clonixin; Dairying; Dinoprost; Drug Combinations; Endometritis; Estonia; Female; Fertility; Inflammation; Postpartum Period; Puerperal Infection | 2012 |
Effect of oral administration of flunixin meglumine on the inflammatory response to endotoxin in heifers.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Cattle; Cattle Diseases; Clonixin; Dinoprost; Endotoxins; Escherichia coli; Female; Hydrocortisone; Inflammation; Injections, Intravenous; Leukocyte Count; Leukocytes, Mononuclear; Neutrophils | 1996 |
16 other study(ies) available for flunixin meglumine and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Effect of Firocoxib and Flunixin Meglumine on Large Colon Mural Thickness of Healthy Horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Horses; Humans; Inflammation; Omeprazole | 2023 |
Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Count; Clonixin; Cyclooxygenase Inhibitors; Epithelial Cells; Escherichia coli; Female; Inflammation; Ketoprofen; Lipopolysaccharides; Mammary Glands, Animal; Mastitis, Bovine; Meloxicam; Milk; Tumor Necrosis Factor-alpha | 2020 |
Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cattle; Chromatography, Liquid; Clonixin; Horse Diseases; Horses; Inflammation; Tandem Mass Spectrometry | 2021 |
Evaluation of flunixin meglumine pour-on administration on prostaglandin E
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Clonixin; Dinoprostone; Exudates and Transudates; Inflammation; Random Allocation | 2017 |
Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Clonixin; Drug Labeling; Drug Residues; Female; Inflammation; Kidney; Lipopolysaccharides; Liver; Milk; Muscle, Skeletal; Sodium Chloride; Veterinary Drugs | 2015 |
In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD1; Biomarkers; Caspase 1; CD4 Antigens; Chemokine CCL2; Clonixin; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Inflammation; Lipopolysaccharides; Male; Real-Time Polymerase Chain Reaction; Serum Amyloid A Protein; Swine; Swine Diseases; Thromboxane B2 | 2012 |
Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Clonixin; Female; Gene Expression Regulation; Horse Diseases; Horses; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; Pyruvates; Tumor Necrosis Factor-alpha | 2013 |
Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cell Line; Clonixin; Cyclooxygenase Inhibitors; Enzyme Induction; Inflammation; Inhibitory Concentration 50; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sheep | 2003 |
Flunixin inhibits prostaglandin E2 production in equine inflammation.
Topics: Animals; Carrageenan; Clonixin; Depression, Chemical; Dinoprostone; Disease Models, Animal; Exudates and Transudates; Female; Horse Diseases; Horses; Inflammation; Male; Nicotinic Acids; Prostaglandins E; Proteins; Time Factors | 1984 |
Non-steroidal anti-inflammatory agents in the horse.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Horse Diseases; Horses; Inflammation; Meclofenamic Acid; Naproxen; Phenylbutazone | 1981 |
Comparative study of the action of flunixin meglumine and tolfenamic acid on prostaglandin E2 synthesis in bovine inflammatory exudate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Clonixin; Dinoprostone; Disease Models, Animal; Exudates and Transudates; Inflammation; Male; ortho-Aminobenzoates; Random Allocation | 1994 |
Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Dinoprostone; Equidae; Female; Inflammation; Metabolic Clearance Rate | 1996 |
Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Clonixin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diffusion Chambers, Culture; Dinoprostone; Inflammation; Isoenzymes; Leukocyte Count; Leukotriene B4; Male; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Sheep; Skin Temperature; Thromboxane B2 | 1998 |
Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Carrageenan; Clonixin; Cross-Over Studies; Exudates and Transudates; Half-Life; Inflammation; Injections, Intravenous; Male; Oxyphenbutazone; Phenylbutazone; Sheep | 1998 |
Effects of flunixin meglumine and dexamethasone on aqueous protein values after intraocular surgery in the dog.
Topics: Animals; Aqueous Humor; Clonixin; Dexamethasone; Dog Diseases; Dogs; Drug Therapy, Combination; Eye Proteins; Inflammation; Nicotinic Acids; Ophthalmologic Surgical Procedures; Postoperative Complications; Random Allocation | 1987 |